Results 1 to 10 of about 92,350 (272)
Shatara V Townes,1 Daniel E Furst,1 Anuradha Thenkondar21Department of Rheumatology, University of California-Los Angeles, Los Angeles, CA, USA; 2Sri Ramachandra Medical College and Research Institute, Chennai, IndiaObjective: To determine the impact of ...
Townes SV, Furst DE, Thenkondar A
doaj +1 more source
Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study [PDF]
Background Itolizumab downregulates the synthesis of proinflammatory cytokines and adhesion molecules by inhibiting CD6 leading to lower levels of interferon-γ, interleukin-6, and tumor necrotic factor-α and reduced T-cell infiltration at inflammatory ...
Abhyuday Kumar +6 more
doaj +1 more source
Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA).
Asumi Tada +3 more
doaj +1 more source
The effect of tocilizumab administration on inflammatory markers in COVID-19 patients
Background The COVID-19 outbreak was declared a worldwide emergency as a result of its rapid spread. The number of people infected with COVID-19 is increasing rapidly around the world, and pneumonia can develop in COVID-19 cases.
Engy Mohamed Riyad Soliman +3 more
doaj +1 more source
Background Localised scleroderma is a rare autoimmune connective tissue disorder characterized by excessive collagen deposition leading to skin fibrosis.
Yang Shen +9 more
doaj +1 more source
BackgroundIn the context of the cytokine storm the takes place in severe COVID-19 patients, the Interleukin 6 (IL6) pathway emerges as one of the key pathways involved in the pathogenesis of this hyperinflammatory state.
Alejandro Durán-Sotuela +7 more
doaj +1 more source
Objective The objective of this study was to assess the value of 18F‐fluorodeoxyglucose (FDG)– positron emission tomography (PET) scans to monitor disease activity in patients with giant cell arteritis (GCA) on tocilizumab. Methods Patients with GCA were
Kaitlin A. Quinn +2 more
doaj +1 more source
High Mortality Rate in Severe COVID-19 Despite Tocilizumab Administration: A Case Series
Introduction: Tocilizumab is a potential therapeutic agent for modulating cytokine storms, a known cause of multiorgan failure and mortality in severe COVID-19.
Cokorda Agung Wahyu Purnamasidhi +4 more
doaj +1 more source
Chunlan Fu,1 Yuanyuan Zhu,2 Weijia Huang,2 Yi Luo,2 Yongxian Hu,2 He Huang,2 Jie Sun2 1Department of Hematology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, Zhejiang, 311800, People’s Republic of China; 2Transplantation Center, The ...
Fu C +6 more
doaj
Effects of fixed dose versus weight-based tocilizumab on thyroid eye disease: a single-centre retrospective observational pilot study. [PDF]
Yang B, Liu X, Sun J, Gu J.
europepmc +1 more source

